Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marietta Stadler

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Wiener Klinische Wochenschrift|April 8, 2016
[Insulin pump therapy in children, adolescents and adults]Marietta Stadler, Sandra Zlamal-Fortunat, Ingrid Schütz-Fuhrmann, et al.
Diabetes, Obesity & Metabolism|February 19, 2026
A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesisRachael J L Tan, Anusha Ahuja, Aakanksha Shrestha, et al.
Diabetes, Obesity & Metabolism|June 4, 2020
Insulin clearance as the major player in the hyperinsulinaemia of black African men without diabetesMeera Ladwa, Oluwatoyosi Bello, Olah Hakim, et al.
Cardiovascular Research|April 25, 2014
Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohortsAnja Laschkolnig, Barbara Kollerits, Claudia Lamina, et al.
The Lancet. Diabetes & Endocrinology|February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trialIda Pernicova, Stephen Kelly, Sharon Ajodha, et al.
Lancet (London, England)|August 28, 2015
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetesHood Thabit, Daniela Elleri, Lalantha Leelarathna, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 29, 2024
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCTAndrew Healey, Tayana Soukup, Nick Sevdalis, et al.
Nature Communications|April 28, 2022
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)Stephanie A Amiel, Laura Potts, Kimberley Goldsmith, et al.
BMJ Open|June 19, 2019
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitionsStephanie A Amiel, Pratik Choudhary, Peter Jacob, et al.
Diabetes Technology & Therapeutics|August 5, 2015
Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living ConditionsHood Thabit, Lalantha Leelarathna, Malgorzata E Wilinska, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Wiener Klinische Wochenschrift|April 8, 2016
[Insulin pump therapy in children, adolescents and adults]Marietta Stadler, Sandra Zlamal-Fortunat, Ingrid Schütz-Fuhrmann, et al.
Diabetes, Obesity & Metabolism|February 19, 2026
A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesisRachael J L Tan, Anusha Ahuja, Aakanksha Shrestha, et al.
Diabetes, Obesity & Metabolism|June 4, 2020
Insulin clearance as the major player in the hyperinsulinaemia of black African men without diabetesMeera Ladwa, Oluwatoyosi Bello, Olah Hakim, et al.
Cardiovascular Research|April 25, 2014
Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohortsAnja Laschkolnig, Barbara Kollerits, Claudia Lamina, et al.
The Lancet. Diabetes & Endocrinology|February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trialIda Pernicova, Stephen Kelly, Sharon Ajodha, et al.
Lancet (London, England)|August 28, 2015
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetesHood Thabit, Daniela Elleri, Lalantha Leelarathna, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 29, 2024
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCTAndrew Healey, Tayana Soukup, Nick Sevdalis, et al.
Nature Communications|April 28, 2022
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)Stephanie A Amiel, Laura Potts, Kimberley Goldsmith, et al.
BMJ Open|June 19, 2019
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitionsStephanie A Amiel, Pratik Choudhary, Peter Jacob, et al.
Diabetes Technology & Therapeutics|August 5, 2015
Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living ConditionsHood Thabit, Lalantha Leelarathna, Malgorzata E Wilinska, et al.
Pageof 6